Healthways (TVTY) Receives Daily Coverage Optimism Score of 0.27

Headlines about Healthways (NASDAQ:TVTY) have been trending positive on Tuesday, Accern reports. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Healthways earned a news sentiment score of 0.27 on Accern’s scale. Accern also gave news coverage about the company an impact score of 45.3169374885698 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Here are some of the media headlines that may have effected Accern Sentiment’s rankings:

Healthways (TVTY) traded down 0.12% during trading on Tuesday, reaching $40.70. The company’s stock had a trading volume of 134,048 shares. The firm has a market capitalization of $1.60 billion, a price-to-earnings ratio of 18.33 and a beta of 0.38. The stock’s 50-day moving average is $39.56 and its 200 day moving average is $36.38. Healthways has a 52-week low of $19.25 and a 52-week high of $43.00.

Healthways (NASDAQ:TVTY) last issued its quarterly earnings data on Thursday, July 27th. The company reported $0.41 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.38 by $0.03. Healthways had a return on equity of 29.81% and a net margin of 17.30%. The business had revenue of $138.90 million for the quarter, compared to the consensus estimate of $138.15 million. The firm’s revenue was up 11.1% compared to the same quarter last year. On average, analysts predict that Healthways will post $1.53 EPS for the current fiscal year.

TVTY has been the subject of a number of analyst reports. ValuEngine upgraded Healthways from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Jefferies Group LLC restated a “buy” rating and issued a $46.00 price target on shares of Healthways in a report on Monday, September 25th. UBS AG upped their price target on Healthways from $37.00 to $43.00 and gave the stock a “buy” rating in a report on Friday, June 23rd. SunTrust Banks, Inc. restated a “buy” rating and issued a $46.00 price target on shares of Healthways in a report on Thursday, October 12th. Finally, Zacks Investment Research upgraded Healthways from a “sell” rating to a “hold” rating in a report on Thursday, October 5th. Three investment analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Healthways currently has an average rating of “Buy” and an average price target of $43.14.

ILLEGAL ACTIVITY WARNING: This piece of content was reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/10/17/healthways-tvty-receives-daily-coverage-optimism-score-of-0-27.html.

In other Healthways news, insider Glenn Hargreaves sold 23,448 shares of the firm’s stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $37.78, for a total value of $885,865.44. Following the sale, the insider now owns 62,211 shares of the company’s stock, valued at approximately $2,350,331.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Conan Laughlin sold 1,750,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $37.90, for a total value of $66,325,000.00. The disclosure for this sale can be found here. Insiders sold a total of 1,824,858 shares of company stock worth $69,172,017 over the last three months. 8.42% of the stock is owned by company insiders.

Healthways Company Profile

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Insider Buying and Selling by Quarter for Healthways (NASDAQ:TVTY)

Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply